SCHEMBL6653941

SCHEMBL6653941

CC(C)=CCOc1cc(OCC=C(C)C)cc(C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.51
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MTNR1A P48039 1/20 0.43
MAOB P27338 3/20 0.43
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
NR1I2 O75469 1/20 0.42
LMNA P02545 1/20 0.42
PGR P06401 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653790 0.86 ALOX15 (0.51) KDM4EALDH1A1MTNR1AMAPTHPGD
SCHEMBL6654666 0.86 ALOX15 (0.51) KDM4EALDH1A1MTNR1AMAPTHPGD
SCHEMBL3316075 0.83 KMT2A (0.60) KMT2AAKR1C3MAOB
SCHEMBL18010031 0.83 AKR1C4 (0.43) AKR1C4AKR1C3AKR1C2AKR1C1KDM4E
Valencic Acid SCHEMBL3316632 0.82 PKM (0.53) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL6652481 0.79 PTGS2 (0.45) KDM4EALDH1A1MTNR1AMAPTHPGD
SCHEMBL4654829 0.79 MGAM (0.47) KDM4EALDH1A1MTNR1AMAPTHPGD
SCHEMBL4654826 0.79 MGAM (0.47) KDM4EALDH1A1MTNR1AMAPTHPGD
SCHEMBL20838307 0.78 MEN1 (0.51) PLA2G2AKMT2AMEN1KDM4EALDH1A1
SCHEMBL6654614 0.77 TPMT (0.53) KDM4EMTNR1AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0875501-B1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO LTD (JP) 2004-06-16 EP disclosed
EP-0802196-B1 Alkylenediamine derivatives as drugs for the treatment of ulcers and the inhibition of Helicobacter pylori SHISEIDO CO LTD (JP) 2001-08-29 EP disclosed
US-6043243-A Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO., LTD. (JP) 2000-03-28 US disclosed
US-6001880-A DISUBSTITUTED N-(2-DIALKYLAMINOETHYL)BENZAMIDE DERIVATIVES OF GIVEN FORMULA; ANTIBACTERIAL ACTIVITY AGAINST HELICOBACTER PYROLI, ADMINISTERING FOR THE PREVENTION OR CURE OF PEPTIC ULCERS SHISEIDO CO., LTD. (JP) 1999-12-14 US disclosed
US-5925667-A INHIBITS GROWTH OF HELICOBACTER PYLORI SHISEIDO CO., LTD. (JP) 1999-07-20 US disclosed
EP-0875501-A2 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-11-04 EP disclosed
EP-0869118-A1 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-10-07 EP disclosed
US-5814634-A PEPTIC ULCERS, GASTRIC ULCERS SHISEIDO CO. LTD. (JP) 1998-09-29 US disclosed
EP-0802196-A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1997-10-22 EP disclosed